Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Post-Market Clinical Study Using TRAQ™ for Minimally Invasive Posterior Sacroiliac Joint Fusion

View source ↗

Summary

A post-market clinical study using the TRAQ sacroiliac joint fusion device by PainTEQ, LLC is not yet recruiting to evaluate outcomes in sacroiliac joint dysfun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRAQ™ Sacroiliac Joint Fusion Device (TRAQ sacroiliac joint fusion device)

Snippet

Sponsor: PainTEQ, LLC | Conditions: Sacroiliac Joint Dysfunction, Sacroiliac Joint Pain | Status: NOT_YET_RECRUITING